Evidence map›Paper›PMID 31201646›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2019

Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration.

Yvette J E Sloot, Katrin Rabold, Thomas Ulas, Dennis M De Graaf, Bas Heinhuis, Kristian Händler, Joachim L Schultze, Mihai G Netea, Johannes W A Smit, Leo A B Joosten and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 4 countries.

Yvette J E SlootDepartment of Internal Medicine (463), Division of Endocrinology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, The Netherlands. Yvette.Sloot@radboudumc.nl.ORCID http://orcid.org/0000-0003-2975-1935
Katrin RaboldDepartment of Internal Medicine (463), Division of Endocrinology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, The Netherlands.
Thomas UlasGenomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany.
Dennis M De GraafDepartment of Internal Medicine (463), Division of Endocrinology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, The Netherlands.
Bas HeinhuisDepartment of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Centre, Nijmegen, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, The Netherlands.
Kristian HändlerGenomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany.
Joachim L SchultzeGenomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany.
Mihai G NeteaGenomics & Immunoregulation, LIMES-Institute, University of Bonn, Bonn, Germany.
Johannes W A SmitDepartment of Internal Medicine (463), Division of Endocrinology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, The Netherlands.
Leo A B JoostenDepartment of Internal Medicine and Radboud Center for Infectious Diseases (RCI), Radboud University Medical Centre, Nijmegen, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, The Netherlands.
Romana T Netea-MaierDepartment of Internal Medicine (463), Division of Endocrinology, Radboud University Medical Center, Geert Grooteplein Zuid 8, 6525, GA, Nijmegen, The Netherlands. Romana.Netea-Maier@radboudumc.nl.
Radboud University Nijmegen · NLUniversity of Bonn · DE

Funding

KWF Kankerbestrijding 10559NWO Spinoza
6 · The paper itself

Abstract

purposeInterleukin 32 (IL-32) is a pro-inflammatory cytokine of which different isoforms have been identified. Recently, IL-32 has been shown to act as a potent inducer of cell migration in several types of cancer. Although previous research showed that IL-32 is expressed in differentiated thyroid cancer (TC) cells, the role of IL-32 in TC cell migration has not been investigated. Furthermore, tumour-associated macrophages (TAMs) may play a facilitating role in cancer cell migration. The aim of this study was to explore whether the interaction between TC cells and TAMs results in increased expression of IL-32 in TC cells and to investigate whether this affects TC cell migration.

methodsTPC-1 cells were co-culture with TC-induced or naive macrophages. Next, transcriptome analysis on TPC-1 cells was performed and supernatants were used for stimulation of TPC-1 cells. IL-32β and IL-32γ were exogenously overexpressed in TPC-1 cells using transient transfection, after which an in vitro gap closure assay was performed to assess cell migration, and the expression of migratory factors was assessed using RT-qPCR.

resultsWe found that TC-induced macrophages induced IL-32 expression in TC cells and that TAM-derived TNFα was the main inducer of IL-32β expression in TC cells. Overexpression of IL-32β and IL-32γ did not affect TC cell migration, but increased cell death. Finally, we found that IL-32β overexpression led to increased mRNA expression of the pro-survival cytokine IL-8, while the expression of other migratory factors was not affected.

conclusionsFrom our data, we conclude that TAM-derived TNFα induces IL-32β in TC cells. Although IL-32β does not affect TC cell migration, alternative splicing of IL-32 towards the IL-32β isoform may be beneficial for TC cell survival through induction of the pro-survival cytokine IL-8.

Indexed as

Alternative SplicingCell DeathCell Line, TumorCell MovementCells, CulturedHumansInterleukin-8InterleukinsKi-67 AntigenMacrophagesMonocytesProtein IsoformsThyroid NeoplasmsTranscriptomeTumor Necrosis Factor-alphaIL32 protein, humanInterleukin-8InterleukinsKi-67 AntigenProtein IsoformsTumor Necrosis Factor-alphaCancer cell deathCancer cell migrationIL-32Thyroid cancer

Identifiers

PMID31201646
PMCPMC12994284
OpenAlexW2953255610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.